News

Dr. Nathan Price at the Vancouver Bioinformatics Users Group 2012: “Integrated modeling of metabolic and regulatory networks”

In this presentation at the the Vancouver Bioinformatics Users Group from 2012, Nathan Price  discusses approaches for the creation of quantitative systems models that can harness the power of genomics, by linking genotype to phenotype. The talk focuses particularly on automated methods for integrating metabolic and regulatory networks, such as Probabilistic Regulation of Metabolism (PROM) (Chandrasekaran and Price, PNAS, 2010). PROM is notable in that it represents the successful integration of a top-down reconstructed, statistically inferred regulatory network with a bottom-up reconstructed, biochemically detailed metabolic network, bridging two important classes of systems biology models that are rarely combined quantitatively. A strategy to curate the inference of regulatory interactions from high throughput data using metabolic networks is discussed—providing multiple layers of biological context to the problem of regulation. Finally, an approach for building tissue and cell type specific metabolic models is also presented, applied to 131 different cell types and tissues in the human body.

The Vancouver Bioinformatics Users Group (VanBUG) is an association of Bioinformatics enthusiast in the B.C. Lower Mainland, Canada.

Recent Articles

  • The Aging Microbiome

    Gut Microbiome Implicated in Healthy Aging and Longevity

    The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are associated with either healthy or unhealthy aging trajectories, which in turn predict survival in a population of older individuals.

  • Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

    NIAID Director Dr. Anthony Fauci sat down for a conversation with ISB’s Dr. Lee Hood. The renowned scientists spoke about the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19, lessons learned from the COVID-19 pandemic, and much more.

  • Priyanka Baloni

    Bile Acids Provide More Evidence of the Gut Microbiome’s Effect on Alzheimer’s Disease

    ISB researchers and their collaborators are looking beyond the one-drug, one-solution approach that has thus far failed in Alzheimer’s disease research. Instead, they are focusing on other promising research avenues, such as the possible role of the gut microbiome in dementia.